4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001662521-26-000002
Director sold 1,626 shares at $102.80 ($167,153)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Connaughton Bernadette · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-10 | Sale : show line 1 in the form 10b5-1 | −1,626 | $102.80 | $167,153 | 40,418 | D |
| Open-market sales · 1,626 sh · avg $102.80 · $167,153 | ||||||
Loading xslF345X06/wk-form4_1786484634.xml…